Additionally, we further analyzed the association between GSN expression level and bladder cancer molecular subtypes (neuronal, basal squamous, luminal, luminal infiltrated and luminal papillary) and found that the GSN expression level was downregulated in all subtypes compared to their normal counterparts (p < 0.01, Figure 7c). This evidence concerns the gene GSN and urinary bladder cancer.